Yi Xiao
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 19
- Cancer, Hypoxia, and Metabolism 3
- Oncology 20
- Cancer Immunotherapy and Biomarkers 15
- PARP inhibition in cancer therapy 3
- Co-authors
- Yi‐Zhou Jiang (38 shared papers)Zhi‐Ming Shao (22 shared papers)Ding Ma (10 shared papers)Song‐Yang Wu (5 shared papers)Da‐Qiang Li (7 shared papers)Xin Hu (5 shared papers)Ding Ma (2 shared papers)Xi Jin (14 shared papers)
- Journals
- Cell Metabolism (4 papers)Cell Reports Medicine (4 papers)Nature Communications (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yi Xiao
49 papers receiving 3k citations
Yi Xiao's Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 978
- Oncology 821
- Radiology, Nuclear Medicine and Imaging 298
- Molecular Biology 723
- Immunology 214
Countries citing papers authored by Yi Xiao
This map shows the geographic impact of Yi Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xiao more than expected).
Fields of papers citing papers by Yi Xiao
This network shows the impact of papers produced by Yi Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xiao. The network helps show where Yi Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets Hit paper breakdown → | 2020 | 350 |
| 2 | Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response Hit paper breakdown → | 2021 | 347 |
| 3 | The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Hit paper breakdown → | 2022 | 345 |
| 4 | 2019 | 288 | |
| 5 | Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Hit paper breakdown → | 2022 | 251 |
| 6 | Emerging therapies in cancer metabolism Hit paper breakdown → | 2023 | 182 |
| 7 | Radiomics in breast cancer: Current advances and future directions Hit paper breakdown → | 2024 | 96 |
| 8 | 2021 | 89 | |
| 9 | Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets Hit paper breakdown → | 2023 | 89 |
| 10 | 2023 | 83 | |
| 11 | 2021 | 78 | |
| 12 | 2022 | 77 | |
| 13 | 2023 | 52 | |
| 14 | 2023 | 52 | |
| 15 | 2018 | 51 | |
| 16 | 2022 | 47 | |
| 17 | 2021 | 46 | |
| 18 | 2024 | 46 | |
| 19 | 2023 | 45 | |
| 20 | 2019 | 43 |
About Yi Xiao
Yi Xiao is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Pathology and Forensic Medicine, having authored 56 papers that have together received 3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Cancer Immunotherapy and Biomarkers (15 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune cells in cancer (3 papers), BRCA gene mutations in cancer (3 papers), Breast Lesions and Carcinomas (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Cancer Research (978 citations), Oncology (821 citations), Radiology, Nuclear Medicine and Imaging (298 citations), Molecular Biology (723 citations) and Immunology (214 citations). Yi Xiao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yi‐Zhou Jiang, Zhi‐Ming Shao, Ding Ma, Song‐Yang Wu, Da‐Qiang Li, Xin Hu, Ding Ma, Xi Jin, Zhi-Ming Shao and Tian‐Jian Yu. Their work appears in journals such as Cell Metabolism, Cell Reports Medicine, Nature Communications, Journal for ImmunoTherapy of Cancer and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.